Stock listing

BMV:PRCT PROCEPT BioRobotics Corporation Acciones

Mexican listing (BMV) of PROCEPT BioRobotics Corporation · home listing NASDAQ:PRCT

Follow PROCEPT BioRobotics Corporation into a list and get an email when it puts out news.

Home listing price · NASDAQ:PRCT

$24.70 USD -0.48 (-1.9%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:PRCT

Past year -11.4% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$24.64 – $26.52 USDNov 20, 2026
Volume
1.04M sharesNov 20, 2026
Market cap
$1.42B USDAt the close on Nov 20, 2026 · price × 57.54M shares outstanding
52-week range
$16.67 – $38.11 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$25.99M USDMedian day 1.19M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
PROCEPT BioRobotics Corporation logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:PRCT · Home$24.70 USD-0.48 (-1.9%)1,037,512$25.38$26.52$24.64$25.18Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:PRCT · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$24.70-0.48-1.9%$25.38$26.52$24.641,037,512
$25.18+1.40+5.9%$23.66$25.84$23.552,048,401
$23.78+0.24+1.0%$23.36$24.11$23.031,335,359
$23.54-0.26-1.1%$23.71$24.29$23.22957,956
$23.80+0.29+1.2%$23.65$24.14$23.241,677,806
$23.51+0.17+0.7%$23.28$24.31$23.141,347,771
$23.34+0.29+1.3%$22.97$23.36$22.55970,485
$23.05+0.68+3.0%$22.25$23.44$21.891,789,766
$22.37+1.75+8.5%$20.73$22.62$20.671,716,022
$20.62+0.35+1.7%$20.14$20.80$19.411,713,534
$20.27-1.39-6.4%$21.53$24.07$19.992,973,299
$21.66+1.49+7.4%$20.70$23.19$20.702,822,240
$20.17+0.73+3.8%$19.27$20.33$19.001,295,562
$19.44+0.24+1.3%$19.33$19.85$19.091,272,049
$19.20-1.10-5.4%$20.33$20.37$18.90856,452
$20.30+0.10+0.5%$20.41$20.67$20.06704,343
$20.20+0.40+2.0%$19.65$20.32$19.65904,691
$19.80-0.03-0.2%$19.82$19.91$19.43708,661
$19.83-0.13-0.7%$19.93$20.21$19.36701,727
$19.96-0.07-0.3%$19.90$20.12$18.75773,700
$20.03+1.76+9.6%$18.24$20.05$18.231,191,000
$18.27-0.55-2.9%$18.54$18.98$18.12733,200
$18.82+0.54+3.0%$18.32$19.11$18.22985,500
$18.28+0.71+4.0%$17.62$18.32$17.531,013,000
$17.57-0.58-3.2%$18.35$18.67$17.521,199,100
$18.15+0.64+3.7%$17.58$18.23$17.581,247,800
$17.51-1.59-8.3%$19.00$19.02$17.491,725,600
$19.10-0.47-2.4%$19.73$19.87$18.681,814,400
$19.57+1.17+6.4%$18.48$19.80$18.462,045,300
$18.40+0.50+2.8%$17.78$18.44$17.781,113,900
$17.90-0.01-0.1%$17.80$18.03$17.521,180,400
$17.91+0.40+2.3%$17.63$18.46$17.631,149,500
$17.51-0.31-1.7%$17.82$18.00$17.22949,300
$17.82+0.66+3.8%$17.16$18.09$17.13971,000
$17.16+0.14+0.8%$17.19$17.91$16.951,240,700
$17.02-1.20-6.6%$18.26$18.46$16.741,604,700
$18.220.000.0%$18.09$18.50$17.691,594,600
$18.22+0.97+5.6%$17.37$18.67$16.802,186,700
$17.25+0.05+0.3%$17.23$17.46$16.801,749,300
$17.20-0.30-1.7%$17.37$17.69$17.051,952,400
$17.50-0.59-3.3%$18.22$18.40$17.251,350,400
$18.09-0.34-1.8%$18.34$18.62$17.95914,700
$18.43-0.08-0.4%$18.87$19.20$18.401,172,100
$18.51-0.79-4.1%$19.31$19.38$18.411,114,500
$19.30-0.17-0.9%$19.42$19.51$18.991,491,200
$19.47+0.03+0.2%$19.58$19.58$19.04850,000
$19.44+0.14+0.7%$19.20$19.96$18.901,295,800
$19.30-1.72-8.2%$20.82$20.91$19.231,997,900
$21.02+0.64+3.1%$20.58$21.50$20.581,682,800
$20.38+0.31+1.5%$20.23$20.67$19.551,573,200
$20.07-0.67-3.2%$20.42$20.65$19.76975,500
$20.74-0.61-2.9%$21.22$21.44$20.601,069,600
$21.35-1.41-6.2%$22.49$22.56$20.851,782,600
$22.76+1.39+6.5%$21.19$22.84$20.891,275,000
$21.37-0.60-2.7%$22.13$22.49$20.84861,000
$21.97+1.06+5.1%$20.86$22.09$20.801,277,800
$20.91-0.29-1.4%$21.15$21.23$20.331,070,100
$21.20+0.37+1.8%$20.76$21.26$20.38939,800
$20.83+0.23+1.1%$20.76$20.97$20.42687,200
$20.60-0.47-2.2%$21.34$21.34$20.471,107,400
$21.07-0.53-2.5%$21.28$21.41$20.88770,300
$21.60+0.35+1.6%$21.25$21.67$21.04595,427
$21.25-0.43-2.0%$21.66$21.68$21.04756,581
$21.68+0.95+4.6%$20.77$22.00$20.77821,800
$20.73-1.18-5.4%$21.87$21.90$20.691,293,400
Ticker
BMV:PRCT
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
BMV
Currency
MXN

What changed lately

Latest news

All PROCEPT BioRobotics Corporation news

PROCEPT BioRobotics Corporation on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
18 in the last 12 months · 102 in all · newest Nov 18, 2026 · oldest 2021
Calls
21 calls with a replay · 21 with a transcript · latest Nov 4, 2026
Decks
8 decks · latest May 2026

Where PROCEPT BioRobotics Corporation is listed

ListingExchangeCountryCurrency
NASDAQ:PRCT · Home listingNASDAQUnited StatesUSD
BMV:PRCT · This pageBMVMexicoMXN
BIVA:PRCTBIVAMexicoMXN
BOATS:PRCTBOATSUnited StatesUSD
BX Swiss:PRCTBX SwissSwitzerlandCHF

Valuation

EV/sales 3.6× against a median of 5.1×: 5th lowest of 11 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$1.25B USD
P/E
Loss
EV/sales
3.6×
EV/EBITDA
Negative EBITDA
Price/book
4.3×
Gross margin
64.7%
Operating margin
−33.6%
Net margin
−32.6%
Debt to equity
0.2×
Beta vs S&P 500
0.89

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
PROCEPT BioRobotics Corporation · NASDAQ:PRCTUS$1.42BUS$1.25Bn/a3.6×n/a4.3×−32.6%0.2×0.89
Shanghai MicroPort Endovascular MedTech Co., Ltd Class A · SSE:688016US$1.52BUS$1.21B17.4×5.5×n/a2.4×40.1%0.0×n/a
Kestra Medical Technologies, Ltd. · NASDAQ:KMTSUS$1.50BUS$1.37Bn/a12.8×n/a6.7×−140.4%0.3×1.66
Vitrolife AB · OMXSTO:VITRUS$1.49BUS$1.58Bn/a4.7×n/a1.9×−144.2%0.2×n/a
Enovis Corporation · NYSE:ENOVUS$1.47BUS$2.66Bn/a1.1×n/a1.0×−22.9%0.8×0.95
Insight Lifetech Co Ltd · SSE:688712US$1.47BUS$1.30B72.7×12.1×n/a5.2×18.8%0.0×n/a
El.En. S.p.A. · MIL:ELNUS$1.44BUS$1.25B30.3×1.9×12.9×3.2×7.3%0.0×n/a
CONMED Corporation · NYSE:CNMDUS$1.39BUS$2.16B29.6×1.6×18.1×1.3×3.4%0.8×0.77
Cofoe Medical Technology Co., Ltd. Class A · SZSE:301087US$1.36BUS$930.1M21.9×1.5×n/a1.7×10.0%0.0×n/a
Butterfly Network, Inc. · NYSE:BFLYUS$1.33BUS$1.21Bn/a9.8×n/a7.2×−43.6%0.0×2.86
Beijing Balance Medical Technology Co. Ltd. Class A · SSE:688198US$1.27BUS$1.26B47.8×12.8×n/a7.2×27.2%0.1×n/a
Median of the othersUS$1.45BUS$1.28B30.0×5.1×15.5×2.8×5.3%0.1×1.31

Forecasts

3 strong buy · 2 buy · 9 hold · 1 sell · Analysts' consensus from EODHD, read Nov 19, 2026. Not 6ix's view and not investment advice.

Price target
22.75 USD · Analysts' mean
EPS, year to Dec 2026
-1.72 · 12 analysts
Revenue, year to Dec 2026
395.3M · 14 analysts

Team and board

Officers

OfficerRole
Larry WoodPRESIDENT & CHIEF EXECUTIVE OFFICER
Kevin WatersExecutive VP, Chief Financial Officer
Matt BacsoVP, Investor Relations and Business Operations

Board

DirectorRole
Thomas M. PrescottCHAIRMAN OF THE BOARD
Amy DodrillDIRECTOR
Antal DesaiDIRECTOR
Daniel PuckettDIRECTOR
Elisabeth LittleDIRECTOR
Frederic MollDIRECTOR
Larry WoodPRESIDENT & CHIEF EXECUTIVE OFFICER
Mary GarrettCHAIR OF THE NOMINATING AND ESG COMMITTEE
Michael MackDIRECTOR
Taylor HarrisCHAIR OF THE AUDIT COMMITTEE

Events

Calls

CallWhenStatus
PROCEPT BioRobotics (NASDAQ:PRCT) Q3 2026 Earnings CallWed, Nov 04, 2026 · 4:30 PM ETReplay
PROCEPT BioRobotics (NASDAQ:PRCT) Q2 2026 Earnings CallTue, Aug 04, 2026 · 4:30 PM ETReplay
PROCEPT BioRobotics (NASDAQ:PRCT) Q1 2026 Earnings CallWed, Apr 29, 2026 · 4:30 PM ETReplay
PROCEPT BioRobotics (NASDAQ:PRCT) Q4 2025 Earnings CallWed, Feb 25, 2026 · 4:30 PM ETReplay
PROCEPT BioRobotics (NASDAQ:PRCT) Q3 2025 Earnings CallTue, Nov 04, 2025 · 4:30 PM ETReplay
PROCEPT BioRobotics (NASDAQ:PRCT) Q2 2025 Earnings CallWed, Aug 06, 2025 · 4:30 PM ETReplay
PROCEPT BioRobotics (NASDAQ:PRCT) Q1 2025 Earnings CallThu, Apr 24, 2025 · 8:00 AM ETReplay
PROCEPT BioRobotics (NASDAQ:PRCT) Q4 2024 Earnings CallTue, Mar 04, 2025 · 4:30 PM ETReplay
PROCEPT BioRobotics (NASDAQ:PRCT) Q3 2024 Earnings CallMon, Oct 28, 2024 · 8:00 AM ETReplay
PROCEPT BioRobotics (NASDAQ:PRCT) Q2 2024 Earnings CallThu, Aug 01, 2024 · 4:30 PM ETReplay
All 21 calls
CallWhenStatus
PROCEPT BioRobotics (NASDAQ:PRCT) Q1 2024 Earnings CallWed, May 01, 2024 · 8:00 AM ETReplay
PROCEPT BioRobotics (NASDAQ:PRCT) Q4 2023 Earnings CallTue, Feb 27, 2024 · 4:30 PM ETReplay
PROCEPT BioRobotics (NASDAQ:PRCT) Q3 2023 Earnings CallWed, Nov 01, 2023 · 4:30 PM ETReplay
PROCEPT BioRobotics (NASDAQ:PRCT) Q2 2023 Earnings CallThu, Jul 27, 2023 · 8:00 AM ETReplay
PROCEPT BioRobotics (NASDAQ:PRCT) Q1 2023 Earnings CallThu, Apr 27, 2023 · 8:00 AM ETReplay
PROCEPT BioRobotics (NASDAQ:PRCT) Q4 2022 Earnings CallTue, Feb 28, 2023 · 4:30 PM ETReplay
PROCEPT BioRobotics (NASDAQ:PRCT) Q3 2022 Earnings CallThu, Nov 03, 2022 · 4:30 PM ETReplay
PROCEPT BioRobotics (NASDAQ:PRCT) Q2 2022 Earnings CallThu, Aug 04, 2022 · 4:30 PM ETReplay
PROCEPT BioRobotics (NASDAQ:PRCT) Q1 2022 Earnings CallThu, May 05, 2022 · 4:30 PM ETReplay
PROCEPT BioRobotics (NASDAQ:PRCT) Q4 2021 Earnings CallTue, Mar 08, 2022 · 8:00 AM ETReplay
PROCEPT BioRobotics (NASDAQ:PRCT) Q3 2021 Earnings CallThu, Nov 04, 2021 · 4:30 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 4, 2026 · After close−6.4%
Q2 2026Aug 4, 2026 · After close+5.8%
Q1 2026Apr 29, 2026 · After close+10.7%
Q4 2025Mar 3, 2026+2.5%
Q3 2025Nov 4, 2025 · After close−9.7%
Q2 2025Aug 6, 2025 · After close−13.3%
Q1 2025Apr 24, 2025 · Before open−5.6%
Q4 2024Feb 25, 2025 · After close+8.6%
Q3 2024Oct 28, 2024 · Before open+32.3%
Q2 2024Aug 1, 2024 · After close−7.5%
All 20 quarters
QuarterResultsShare move
Q1 2024May 1, 2024 · Before open+14.4%
Q4 2023Feb 27, 2024 · After close−2.7%
Q3 2023Nov 1, 2023 · After close+18.4%
Q2 2023Jul 27, 2023 · Before open−7.1%
Q1 2023Apr 27, 2023 · Before open−25.3%
Q4 2022Feb 28, 2023 · After close+1.0%
Q3 2022Nov 4, 2022 · After close−1.5%
Q2 2022Aug 5, 2022 · After close−0.1%
Q1 2022May 5, 2022 · After close+0.5%
Q4 2021Mar 8, 2022 · Before open+6.2%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (May 2026)Investor deck16 slidesMay 2026
Investor Presentation (May 2026)Investor deck16 slidesMay 2026
Q4 2025 Earnings PresentationEarnings102 slidesFeb 25, 2026
Investor Day (April 2025)Investor day73 slidesApr 25, 2025
Investor Day (May 2024)Investor day58 slidesMay 3, 2024
Investor Day (April 2023)Investor day44 slidesApr 28, 2023
Investor Day (May 2022)Investor day51 slidesMay 13, 2022
46th Annual William Blair Growth Stock ConferenceConference27 slides

Open Decks

IPO

Priced at US$25.00 a share on Sep 14, 2021.

Price
US$25.00 a share
Shares offered
6,556,000 shares of common stock
Offering size
US$163.9 million
Underwriters' option
Up to 983,400 more shares
Listing
PRCT on the Nasdaq Global Market
Underwriters
BofA Securities, Goldman Sachs & Co. LLC, Cowen, Guggenheim Securities, SVB Leerink · In the order on the cover
Shares delivered
On or about Sep 17, 2021

Steps

StepWhen
Draft sent to the SEC in confidenceJun 25, 2021
Filed publiclyAug 18, 2021
Amended onceSep 8, 2021
Shares registered with an exchangeSep 10, 2021
Declared effective by the SECSep 14, 2021
Final prospectus, with the priceSep 16, 2021

Open IPO · From the cover of the final prospectus (424B4) filed Sep 16, 2021

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue308.1M224.5M136.2M75.0M34.5M7.72M6.17M
Cost of revenue111.8M87.4M65.1M37.9M18.6M8.97M8.05M
Gross profit196.2M137.1M71.0M37.1M15.9M-1.25M-1.89M
Research and development71.3M62.3M48.4M29.0M19.0M16.3M13.1M
Selling, general and administrative228.8M171.4M131.8M88.8M51.0M30.3M28.5M
Operating income-103.9M-96.6M-109.2M-80.7M-54.2M-47.8M-43.5M
Depreciation and amortization6.39M5.23M3.81M2.84M3.32M2.86M1.49M
EBITDA-97.5M-91.4M-105.4M-77.9M-50.8M-44.9M-42.1M
Interest expense3.59M4.18M4.00M5.18M5.81M5.26M724.0K
Income before tax-95.4M-91.0M-105.8M-87.2M-59.9M-53.0M-42.0M
Income tax190.0K368.0K80.0K000678.0K
Net income-95.6M-91.4M-105.9M-87.2M-59.9M-53.0M-42.0M
Earnings per share, basic-1.72-1.75-2.24-1.96-3.63-14.47-1.25
Earnings per share, diluted-1.72-1.75-2.24-1.96-3.63-14.47

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents286.5M333.7M257.2M221.9M304.3M100.1M42.0M
Receivables83.5M83.5M48.4M15.3M4.46M1.55M1.10M
Inventory70.7M56.2M39.8M28.5M13.1M6.92M6.69M
Current assets450.4M481.8M350.6M272.6M326.2M110.3M50.4M
Property, plant and equipment30.4M26.7M28.7M8.66M5.04M8.27M8.27M
Total assets508.1M534.0M404.7M309.3M337.0M126.0M62.0M
Accounts payable17.3M10.0M13.5M9.39M2.03M1.24M1.44M
Current liabilities65.8M53.1M45.9M35.3M16.2M14.5M6.79M
Long-term debt51.6M51.5M51.3M51.2M50.0M44.4M23.2M
Total debt51.6M51.5M51.3M51.2M50.0M49.0M23.2M
Total liabilities142.2M131.8M124.0M112.3M69.9M65.0M32.8M
Shareholders' equity365.9M402.2M280.8M197.1M267.1M-182.9M29.2M
Shares outstanding56.3M54.7M50.8M44.8M43.7M4.71M33.6M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations-49.0M-99.2M-108.0M-80.4M-57.3M-48.3M-43.8M
Capital spending-9.36M-4.41M-25.2M-2.65M-592.0K-233.0K-7.61M
Free cash flow-58.3M-103.6M-133.2M-83.0M-57.9M-48.6M-51.4M
Cash from investing-9.36M-4.41M-25.2M-2.65M-592.0K-233.0K43.2M
Cash from financing11.2M180.1M167.8M3.61M262.1M106.8M26.5M
Share buybacks6.36M4.53M3.61M2.41M177.4M
Change in cash-47.2M76.5M34.6M-79.4M204.2M58.2M25.9M

Open Financials

Filings

FilingDateTypeFiled with
4 · Change in ownershipNov 6, 2026Insider tradeSEC
144 · Notice of proposed saleNov 6, 2026Other filingsSEC
10-Q · Quarterly reportNov 4, 2026Quarterly reportSEC
8-K · Current reportNov 4, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedOct 30, 2026Big-stake noticeSEC
4 · Change in ownershipOct 5, 2026Insider tradeSEC
3 · Initial statement of ownershipOct 5, 2026Insider tradeSEC
8-K · Current reportOct 2, 2026Management or board changeSEC
8-K · Current reportSep 24, 2026Material contractSEC
4 · Change in ownershipSep 10, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipSep 10, 2026Insider tradeSEC
4 · Change in ownershipSep 10, 2026Insider tradeSEC
144 · Notice of proposed saleSep 9, 2026Other filingsSEC
144 · Notice of proposed saleSep 9, 2026Other filingsSEC
144 · Notice of proposed saleSep 9, 2026Other filingsSEC
4 · Change in ownershipAug 14, 2026Insider tradeSEC
4 · Change in ownershipAug 14, 2026Insider tradeSEC
4 · Change in ownershipAug 14, 2026Insider tradeSEC
4 · Change in ownershipAug 14, 2026Insider tradeSEC
4 · Change in ownershipAug 10, 2026Insider tradeSEC
10-Q · Quarterly reportAug 5, 2026Quarterly reportSEC
8-K · Current reportAug 4, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 29, 2026Big-stake noticeSEC
4 · Change in ownershipJun 10, 2026Insider tradeSEC
4 · Change in ownershipJun 10, 2026Insider tradeSEC
4 · Change in ownershipJun 10, 2026Insider tradeSEC
4 · Change in ownershipJun 10, 2026Insider tradeSEC
4 · Change in ownershipJun 10, 2026Insider tradeSEC
4 · Change in ownershipJun 10, 2026Insider tradeSEC
4 · Change in ownershipJun 10, 2026Insider tradeSEC
4 · Change in ownershipJun 10, 2026Insider tradeSEC
8-K · Current reportJun 10, 2026Meeting outcomeSEC
4 · Change in ownershipJun 10, 2026Insider tradeSEC
4 · Change in ownershipJun 10, 2026Insider tradeSEC
4 · Change in ownershipJun 10, 2026Insider tradeSEC
144 · Notice of proposed saleJun 8, 2026Other filingsSEC
144 · Notice of proposed saleJun 8, 2026Other filingsSEC
144 · Notice of proposed saleJun 8, 2026Other filingsSEC
SD · Specialized disclosureJun 1, 2026ESG reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 18, 2026Big-stake noticeSEC
3 · Initial statement of ownershipApr 30, 2026Insider tradeSEC
10-Q · Quarterly reportApr 30, 2026Quarterly reportSEC
SCHEDULE 13G · Big-stake noticeApr 30, 2026Big-stake noticeSEC
8-K · Current reportApr 29, 2026ResultsSEC
3 · Initial statement of ownershipApr 24, 2026Insider tradeSEC
DEFA14A · Additional proxy materialApr 22, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 22, 2026Meeting noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 27, 2026Big-stake noticeSEC
4 · Change in ownershipMar 19, 2026Insider tradeSEC
144 · Notice of proposed saleMar 19, 2026Other filingsSEC
4 · Change in ownershipMar 19, 2026Insider tradeSEC
4 · Change in ownershipMar 19, 2026Insider tradeSEC
144 · Notice of proposed saleMar 17, 2026Other filingsSEC
144 · Notice of proposed saleMar 17, 2026Other filingsSEC
4 · Change in ownershipMar 12, 2026Insider tradeSEC
144 · Notice of proposed saleMar 10, 2026Other filingsSEC
4 · Change in ownershipMar 9, 2026Insider tradeSEC
4 · Change in ownershipMar 9, 2026Insider tradeSEC
4 · Change in ownershipMar 9, 2026Insider tradeSEC
4 · Change in ownershipMar 9, 2026Insider tradeSEC
4 · Change in ownershipMar 9, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 9, 2026Insider tradeSEC
144 · Notice of proposed saleMar 6, 2026Other filingsSEC
144 · Notice of proposed saleMar 6, 2026Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 6, 2026Big-stake noticeSEC
8-K · Current reportMar 5, 2026Management or board changeSEC
S-8 · Registration statement for employee plansFeb 26, 2026Offer documentSEC
10-K · Annual reportFeb 26, 2026Annual reportSEC
8-K · Current reportFeb 26, 2026Current reportSEC
4 · Change in ownershipFeb 25, 2026Insider tradeSEC
4 · Change in ownershipFeb 25, 2026Insider tradeSEC
8-K · Current reportFeb 25, 2026ResultsSEC
SCHEDULE 13G · Big-stake noticeFeb 17, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeFeb 11, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJan 8, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeNov 14, 2025Big-stake noticeSEC
10-Q · Quarterly reportNov 5, 2025Quarterly reportSEC
8-K · Current reportNov 4, 2025ResultsSEC
8-K · Current reportSep 18, 2025Management or board changeSEC
4 · Change in ownershipSep 4, 2025Insider tradeSEC
4 · Change in ownershipAug 15, 2025Insider tradeSEC
4 · Change in ownershipAug 14, 2025Insider tradeSEC
4 · Change in ownershipAug 14, 2025Insider tradeSEC
10-Q · Quarterly reportAug 7, 2025Quarterly reportSEC
8-K · Current reportAug 6, 2025ResultsSEC
8-K · Current reportJul 24, 2025ResultsSEC
4 · Change in ownershipJun 12, 2025Insider tradeSEC
4 · Change in ownershipJun 12, 2025Insider tradeSEC
4 · Change in ownershipJun 12, 2025Insider tradeSEC
4 · Change in ownershipJun 12, 2025Insider tradeSEC
4 · Change in ownershipJun 12, 2025Insider tradeSEC
4 · Change in ownershipJun 12, 2025Insider tradeSEC
4 · Change in ownershipJun 12, 2025Insider tradeSEC
4 · Change in ownershipJun 12, 2025Insider tradeSEC
8-K · Current reportJun 10, 2025Meeting outcomeSEC
144 · Notice of proposed saleJun 6, 2025Other filingsSEC
4 · Change in ownershipJun 6, 2025Insider tradeSEC
4 · Change in ownershipJun 5, 2025Insider tradeSEC
144 · Notice of proposed saleJun 3, 2025Other filingsSEC
SD · Specialized disclosureMay 29, 2025ESG reportSEC
4 · Change in ownershipMay 13, 2025Insider tradeSEC
10-Q · Quarterly reportMay 2, 2025Quarterly reportSEC
DEFA14A · Additional proxy materialApr 25, 2025Meeting noticeSEC
DEF 14A · Proxy statementApr 25, 2025Meeting noticeSEC
8-K · Current reportApr 25, 2025Current reportSEC
8-K · Current reportApr 24, 2025ResultsSEC
10-K/A · Annual report, amendedApr 11, 2025Annual reportSEC
4 · Change in ownershipMar 19, 2025Insider tradeSEC
4 · Change in ownershipMar 19, 2025Insider tradeSEC
4 · Change in ownershipMar 19, 2025Insider tradeSEC
4 · Change in ownershipMar 19, 2025Insider tradeSEC
144 · Notice of proposed saleMar 18, 2025Other filingsSEC
144 · Notice of proposed saleMar 18, 2025Other filingsSEC
144 · Notice of proposed saleMar 18, 2025Other filingsSEC
144 · Notice of proposed saleMar 18, 2025Other filingsSEC
4 · Change in ownershipMar 10, 2025Insider tradeSEC
4 · Change in ownershipMar 10, 2025Insider tradeSEC
4 · Change in ownershipMar 10, 2025Insider tradeSEC
4 · Change in ownershipMar 10, 2025Insider tradeSEC
144 · Notice of proposed saleMar 6, 2025Other filingsSEC
144 · Notice of proposed saleMar 6, 2025Other filingsSEC
144 · Notice of proposed saleMar 6, 2025Other filingsSEC
144 · Notice of proposed saleMar 6, 2025Other filingsSEC
4 · Change in ownershipMar 5, 2025Insider tradeSEC
4 · Change in ownershipMar 5, 2025Insider tradeSEC
4 · Change in ownershipMar 5, 2025Insider tradeSEC
4 · Change in ownershipMar 5, 2025Insider tradeSEC
S-8 · Registration statement for employee plansFeb 28, 2025Offer documentSEC
10-K · Annual reportFeb 27, 2025Annual reportSEC
8-K · Current reportFeb 25, 2025ResultsSEC
4 · Change in ownershipFeb 12, 2025Insider tradeSEC
4 · Change in ownershipDec 6, 2024Insider tradeSEC
4 · Change in ownershipDec 6, 2024Insider tradeSEC
144 · Notice of proposed saleDec 4, 2024Other filingsSEC
144 · Notice of proposed saleDec 4, 2024Other filingsSEC
4 · Change in ownershipDec 2, 2024Insider tradeSEC
144 · Notice of proposed saleNov 27, 2024Other filingsSEC
4 · Change in ownershipNov 22, 2024Insider tradeSEC
144 · Notice of proposed saleNov 20, 2024Other filingsSEC
4 · Change in ownershipNov 15, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
144 · Notice of proposed saleNov 13, 2024Other filingsSEC
SC 13G/A · Big-stake notice, amendedNov 12, 2024Big-stake noticeSEC
4 · Change in ownershipNov 7, 2024Insider tradeSEC
144 · Notice of proposed saleNov 5, 2024Other filingsSEC
SC 13G/A · Big-stake notice, amendedNov 4, 2024Big-stake noticeSEC
4 · Change in ownershipOct 31, 2024Insider tradeSEC
8-K · Current reportOct 31, 2024Current reportSEC
424B5 · ProspectusOct 30, 2024Offer documentSEC
424B5 · ProspectusOct 28, 2024Offer documentSEC
10-Q · Quarterly reportOct 28, 2024Quarterly reportSEC
8-K · Current reportOct 28, 2024ResultsSEC
4 · Change in ownershipOct 17, 2024Insider tradeSEC
4 · Change in ownershipSep 18, 2024Insider tradeSEC
144 · Notice of proposed saleSep 16, 2024Other filingsSEC
4 · Change in ownershipSep 12, 2024Insider tradeSEC
4 · Change in ownershipSep 5, 2024Insider tradeSEC
144 · Notice of proposed saleSep 4, 2024Other filingsSEC
144 · Notice of proposed saleSep 3, 2024Other filingsSEC
4 · Change in ownershipAug 23, 2024Insider tradeSEC
8-K · Current reportAug 21, 2024Current reportSEC
10-Q · Quarterly reportAug 2, 2024Quarterly reportSEC
8-K · Current reportAug 1, 2024ResultsSEC
4 · Change in ownershipJul 19, 2024Insider tradeSEC
8-K · Current reportJul 19, 2024Management or board changeSEC
10-Q/A · Quarterly report, amendedJun 27, 2024Quarterly reportSEC
4 · Change in ownershipJun 18, 2024Insider tradeSEC
144 · Notice of proposed saleJun 17, 2024Other filingsSEC
4 · Change in ownershipJun 12, 2024Insider tradeSEC
144 · Notice of proposed saleJun 10, 2024Other filingsSEC
4 · Change in ownershipJun 6, 2024Insider tradeSEC
4 · Change in ownershipJun 6, 2024Insider tradeSEC
4 · Change in ownershipJun 6, 2024Insider tradeSEC
4 · Change in ownershipJun 6, 2024Insider tradeSEC
4 · Change in ownershipJun 6, 2024Insider tradeSEC
4 · Change in ownershipJun 6, 2024Insider tradeSEC
4 · Change in ownershipJun 6, 2024Insider tradeSEC
4 · Change in ownershipJun 6, 2024Insider tradeSEC
8-K · Current reportJun 4, 2024Meeting outcomeSEC
SD · Specialized disclosureMay 29, 2024ESG reportSEC
4 · Change in ownershipMay 22, 2024Insider tradeSEC
SC 13D/A · Big-stake notice, amendedMay 22, 2024Big-stake noticeSEC
4 · Change in ownershipMay 7, 2024Insider tradeSEC
4 · Change in ownershipMay 7, 2024Insider tradeSEC
SC 13D/A · Big-stake notice, amendedMay 7, 2024Big-stake noticeSEC
4 · Change in ownershipMay 3, 2024Insider tradeSEC
4 · Change in ownershipMay 3, 2024Insider tradeSEC
144 · Notice of proposed saleMay 3, 2024Other filingsSEC
8-K · Current reportMay 3, 2024Current reportSEC
10-Q · Quarterly reportMay 2, 2024Quarterly reportSEC
144 · Notice of proposed saleMay 1, 2024Other filingsSEC
8-K · Current reportMay 1, 2024ResultsSEC
DEF 14A · Proxy statementApr 22, 2024Meeting noticeSEC
DEFA14A · Additional proxy materialApr 22, 2024Meeting noticeSEC
4 · Change in ownershipApr 19, 2024Insider tradeSEC
4/A · Change in ownership, amendedApr 19, 2024Insider tradeSEC
4/A · Change in ownership, amendedApr 19, 2024Insider tradeSEC
8-K · Current reportApr 19, 2024Management or board changeSEC
4 · Change in ownershipMar 20, 2024Insider tradeSEC
4 · Change in ownershipMar 20, 2024Insider tradeSEC

This page holds 200 of 399 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from PROCEPT BioRobotics Corporation’s releases · as of Oct 29, 2026

Common shares
57,536,121
Fully diluted
57,536,121

Fully diluted

LineSharesAs of
Common shares57,536,121Oct 29, 2026

Share count over time

CountShares
Oct 29, 202657,536,121

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Vanguard5.36M9.3%US$97.7MSep 30, 2026
BlackRock4.85M8.4%US$88.3MSep 30, 2026
T. Rowe Price4.61M8.0%US$83.9MSep 30, 2026
BNP Paribas3.37M5.9%US$61.4MSep 30, 2026
JPMorgan1.91M3.3%US$34.8MSep 30, 2026
Frontier Capital Management Co LLC1.85M3.2%US$33.8MSep 30, 2026
State Street1.69M2.9%US$30.9MSep 30, 2026
Geode Capital1.33M2.3%US$24.3MSep 30, 2026
Janus Henderson1.32M2.3%US$24.1MSep 30, 2026
LMR Partners LLP1.23M2.1%US$22.4MSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Millennium1.22M2.1%US$22.2MSep 30, 2026
Baillie Gifford & Co1.2M2.1%US$21.9MSep 30, 2026
Balyasny Asset Management L.P.1.05M1.8%US$19.1MSep 30, 2026
Morgan Stanley969K1.7%US$17.6MSep 30, 2026
Federated Hermes, Inc.845K1.5%US$15.4MSep 30, 2026
Bank of America842K1.5%US$15.3MSep 30, 2026
Trexquant Investment LP786K1.4%US$14.3MSep 30, 2026
Fiera Capital Corp764K1.3%US$13.9MSep 30, 2026
Hrt Financial LP720K1.3%US$13.1MSep 30, 2026
Goldman Sachs664K1.2%US$12.1MSep 30, 2026
Soleus Capital Management, L.P.600K1.0%US$10.9MSep 30, 2026
Champlain Investment Partners, LLC593K1.0%US$10.8MSep 30, 2026
Northern Trust593K1.0%US$10.8MSep 30, 2026
Two Sigma575K1.0%US$10.5MSep 30, 2026
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.559K0.97%US$10.2MSep 30, 2026
Rhenman & Partners Asset Management AB535K0.93%US$9.75MSep 30, 2026
Bellevue Group AG502K0.87%US$9.15MSep 30, 2026
Chicago Capital, LLC495K0.86%US$9.02MSep 30, 2026
Wellington489K0.85%US$8.92MSep 30, 2026
Bastion Asset Management Inc.447K0.78%US$8.09MSep 30, 2026
Schwab441K0.77%US$8.03MSep 30, 2026
D. E. Shaw & Co., Inc.421K0.73%US$7.67MSep 30, 2026
UBS411K0.71%US$7.49MSep 30, 2026
Blair William & Co410K0.71%US$7.47MSep 30, 2026
AQR Capital Management LLC389K0.68%US$7.09MSep 30, 2026
Rockefeller Capital Management L.P.381K0.66%US$6.93MSep 30, 2026
C WorldWide Group Holding A/S375K0.65%US$6.83MSep 30, 2026
Citigroup Inc369K0.64%US$6.72MSep 30, 2026
Johnson & Johnson358K0.62%US$6.52MSep 30, 2026
Susquehanna347K0.60%US$6.32MSep 30, 2026
Divisadero Street Capital Management, LP324K0.56%US$5.91MSep 30, 2026
Citadel278K0.48%US$5.07MSep 30, 2026
Peregrine Capital Management LLC270K0.47%US$4.91MSep 30, 2026
Barclays266K0.46%US$4.85MSep 30, 2026
Granite Investment Partners, LLC244K0.42%US$4.44MSep 30, 2026
DWS242K0.42%US$4.41MSep 30, 2026
Werba Rubin Papier Wealth Management210K0.36%US$3.83MSep 30, 2026
Voleon Capital Management LP208K0.36%US$3.78MSep 30, 2026
State Of Wisconsin Investment Board207K0.36%US$3.77MSep 30, 2026
Quantinno Capital Management LP206K0.36%US$3.75MSep 30, 2026

This page holds 50 of 222 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
Vanguard Total Stock Market Index Fund1.71M3.0%US$38.6MJun 30, 2026
iShares Russell 2000 ETF1.46M2.5%US$32.9MJun 30, 2026
T. Rowe Price Small-Cap Stock Fund, Inc.1.32M2.3%US$29.8MJun 30, 2026
Vanguard Small-Cap Index Fund1.24M2.2%US$28MJun 30, 2026
Janus Henderson Venture Fund891K1.5%US$20.1MJun 30, 2026
Vanguard Small-Cap Growth Index Fund711K1.2%US$16.1MJun 30, 2026
T. Rowe Price Institutional Small-Cap Stock Fund696K1.2%US$15.7MJun 30, 2026
Vanguard Extended Market Index Fund652K1.1%US$14.7MJun 30, 2026
Federated Hermes MDT Small Cap Core Fund647K1.1%US$12.1MJul 31, 2026
Fidelity Growth Company Fund643K1.1%US$16.9MMay 31, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
T. Rowe Price New Horizons Fund, Inc.615K1.1%US$13.9MJun 30, 2026
Fidelity Small Cap Index Fund614K1.1%US$11.4MJul 31, 2026
iShares Russell 2000 Growth ETF519K0.90%US$11.7MJun 30, 2026
Global X Robotics & Artificial Intelligence ETF425K0.74%US$11.2MMay 31, 2026
Champlain Small Company Fund401K0.70%US$9.05MJun 30, 2026
MFS New Discovery Fund312K0.54%US$8.2MMay 31, 2026
Fidelity Extended Market Index Fund290K0.50%US$7.63MMay 31, 2026
Federated Hermes MDT Small Cap Growth Fund280K0.49%US$5.22MJul 31, 2026
Bridge Builder Small/Mid Cap Growth Fund277K0.48%US$6.27MJun 30, 2026
Vanguard Russell 2000 Index Fund274K0.48%US$7.21MMay 31, 2026
Schwab U.S. Small-Cap ETF270K0.47%US$7.11MMay 31, 2026
iShares U.S. Medical Devices ETF267K0.46%US$6.02MJun 30, 2026
T. Rowe Price Health Sciences Fund, Inc.246K0.43%US$5.56MJun 30, 2026
William Blair Small Cap Growth Fund242K0.42%US$5.46MJun 30, 2026
Artisan Small Cap Fund215K0.37%US$4.85MJun 30, 2026
Strategic Advisers U.S. Total Stock Fund198K0.34%US$5.2MMay 31, 2026
Vanguard Health Care Index Fund168K0.29%US$4.42MMay 31, 2026
State Street(R) SPDR(R) S&P Kensho New Economies Composite ETF140K0.24%US$3.15MJun 30, 2026
Schwab Small-Cap Index Fund137K0.24%US$2.54MJul 31, 2026
Osterweis Opportunity Fund128K0.22%US$2.88MJun 30, 2026
Small Cap Growth Stock Portfolio114K0.20%US$2.59MJun 30, 2026
MFS New Discovery Series113K0.20%US$2.56MJun 30, 2026
Allspring Small Company Growth Fund110K0.19%US$2.04MJul 31, 2026
Fidelity Total Market Index Fund108K0.19%US$2.83MMay 31, 2026
Master Small Cap Index Series105K0.18%US$2.37MJun 30, 2026
Vela Small Cap Fund103K0.18%US$2.33MJun 30, 2026
Fidelity Series Growth Company Fund102K0.18%US$2.7MMay 31, 2026
Fidelity Series Total Market Index Fund85,1030.15%US$2.24MMay 31, 2026
State Street(R) SPDR(R) S&P(R) Health Care Equipment ETF85,0470.15%US$1.92MJun 30, 2026
Hartford Small Cap Growth Hls Fund84,0190.15%US$1.9MJun 30, 2026
Optimum Small-Mid Cap Growth Fund82,1530.14%US$1.86MJun 30, 2026
iShares Core S&P Total U.S. Stock Market ETF75,6430.13%US$1.71MJun 30, 2026
Nuveen Small Cap Blend Index Fund74,3690.13%US$1.38MJul 31, 2026
JNL Multi-Manager Small Cap Growth Fund66,0320.11%US$1.49MJun 30, 2026
State Street Institutional Small-Cap Equity Fund62,0000.11%US$1.4MJun 30, 2026
EQ/2000 Managed Volatility Portfolio61,1300.11%US$1.38MJun 30, 2026
Nuveen Equity Index Fund56,0090.10%US$1.04MJul 31, 2026
Sbh Small Cap Growth Fund55,0270.10%US$1.24MJun 30, 2026
NYLIM Fiera SMID Growth Fund53,5570.09%US$997KJul 31, 2026
Fidelity Small Cap Growth Index Fund52,6460.09%US$1.19MJun 30, 2026

This page holds 50 of 192 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Sharma Pooja
Officer: Chief Strat/Marketing Officer
Sale4,710USD 19.71US$92,853Nov 6, 2026
Templin Barry L
Officer: EVP, Chief Technology Officer
Sale373USD 20.95US$7,814Sep 9, 2026
Nouri Alaleh
Officer: EVP, CLO, CORP. SEC.
Sale297USD 20.95US$6,222Sep 9, 2026
Waters Kevin
Officer: EVP, CFO
Sale373USD 20.95US$7,814Sep 9, 2026
Wood Larry L
Director, Officer: President, CEO
Buy23,900USD 20.85US$498KAug 7, 2026
Templin Barry L
Officer: EVP, Chief Technology Officer
Sale358USD 28.48US$10,196Jun 8, 2026
Waters Kevin
Officer: EVP, CFO
Sale357USD 28.48US$10,167Jun 8, 2026
Nouri Alaleh
Officer: EVP, CLO, CORP. SEC.
Sale285USD 28.48US$8,117Jun 8, 2026

Big stakes

StakeStakeSharesDateFiling
BlackRock, Inc.8.20%4.65MJun 30, 2026Schedule 13G
T. Rowe Price Investment Management, Inc.5.90%3.27MDec 31, 2025Schedule 13G
BNP Paribas ASSET MANAGEMENT Holding S.A.5.50%3.09MDec 31, 2025Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Frederic Moll
Other companies: SS Innovations International Inc. (Vice Chairman · Since at least Aug 20, 2024); Lux Health Tech Acquisition Corp (Director · Oct 26, 2020 – Oct 26, 2020 · Past); Shockwave Medical Inc (Director · Mar 6, 2019 – May 31, 2024 · Past); Venus Concept Inc (Director · Oct 11, 2017 – Nov 7, 2019 · Past); Intersect ENT Inc (Director · Jul 23, 2014 – Jan 19, 2021 · Past); Hansen Medical Inc (Director · Mar 3, 2009 – Mar 1, 2012 · Past)
DIRECTOR · Since at least Sep 14, 2021
Reza Zadno
Other companies: Mobia Medical, Inc. (Board Member · Since at least Jul 14, 2026); Invuity Inc (Director · May 19, 2016 – May 3, 2017 · Past); Carbylan Therapeutics Inc (Director · Aug 3, 2015 – Aug 3, 2015 · Past)
President, CEO, Director · Sep 14, 2021 – May 9, 2025 · Past
Amy M. Dodrill
Other companies: CTS Corporation (Member · Since at least Nov 5, 2026)
DIRECTOR · Since at least Jun 9, 2026
Antal Desai
Other companies: Reata Pharmaceuticals Inc (Director · Sep 26, 2023 – Sep 26, 2023 · Past)
DIRECTOR · Since at least Sep 14, 2021
Daniel Puckett
Other companies: Shockwave Medical Inc (Chief Financial Officer · Oct 15, 2020 – Feb 5, 2024 · Past)
Director · Since at least Mar 5, 2026
Elisabeth Little
Other companies: VYNE Therapeutics Inc. (Director · Since at least Dec 13, 2023)
Director · Since at least Jun 4, 2024
Larry Wood
Other companies: Edwards Lifesciences Corporation (Global President TAVR & Surg · Since at least Apr 5, 2022)
PRESIDENT & CHIEF EXECUTIVE OFFICER · Since at least Apr 18, 2024
Mary Garrett
Other companies: Omnicell, Inc. (Director · Since at least Jun 1, 2026)
Director · Since at least Jun 9, 2026
Taylor Harris
Other companies: Establishment Labs Holdings Inc. (Board Member · Since at least Jun 24, 2026)
Director · Since at least Jun 9, 2026
Thomas M. Krummel
Other companies: California Water Service Group (Director · Since at least Jul 1, 2010)
Director · Sep 14, 2021 – Jun 4, 2024 · Past
All 20 people
PersonSeat
Alaleh NouriEVP, CLO, CORP. SEC. · Since at least Jun 8, 2026
Barry L TemplinEVP, Chief Technology Officer · Since at least Apr 16, 2026
Hisham ShiblaqEVP, Chief Comm. Officer · Since at least Mar 6, 2024
Kevin WatersExecutive VP, Chief Financial Officer · Since at least Feb 19, 2026
Matt BacsoVP, Investor Relations and Business Operations · Since at least Apr 30, 2026
Matt BacsoVPInvestor Relations and Business · Nov 4, 2025 – Nov 5, 2026 · Past
Michael MackDirector · Since at least Oct 2, 2026
Morgan Colby WoodDirector · Sep 14, 2021 – Nov 13, 2023 · Past
Pooja SharmaChief Strat/Marketing Officer · Since at least Apr 16, 2026
Thomas M. PrescottDirector · Since at least Jul 24, 2025

Open People

Log in to ask 6ix AI your own questions about PROCEPT BioRobotics Corporation.